Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is one of the most effective agents in the treatment of superficial bladder cancer. BCG osteomyelitis is an infrequent complication of intravesicular BCG therapy; only five cases of BCG vertebral osteomyelitis have been reported in the literature. Similarly, the infection of an indwelling extravascular device by BCG is rare; there is only one previous report documenting infection associated with an automated implantable cardiac defibrillator. We report a case of BCG osteomyelitis involving a hip arthroplasty that occurred after intravesicular administration of BCG for bladder cancer, and we review the risk factors predisposing to such infections and their treatment.
Mycobacterium bovis Osteomyelitis Involving a Hip Arthroplasty After Intravesicular Bacille Calmette-Guérin for Bladder Cancer
BCG is a live, attenuated strain of Mycobacterium bovis right-lateral-hip pain that radiated to his right knee and foot. Six years before presentation, he underwent a total right-hip that was originally developed in 1921 for vaccination against replacement. Twenty months before presentation, papillary tuberculosis. More recently, there has been growing interest in transitional-cell bladder carcinoma in situ (CIS) was diagnosed. the use of BCG in the treatment of patients with neoplastic
He was treated with 12 weekly instillations of intravesicular diseases. Randomized, controlled trials have shown that BCG is BCG (TICE strain, 60 mg) and then 12 weekly cycles of inthe most effective treatment for superficial bladder carcinoma. travesicular mitomycin (40 mg); ultimately he underwent radiAs the use of BCG immunotherapy increases, we learn more cal cystectomy for persistent CIS. Bilateral iliac and obturator about the spectrum of the complications that follow treatment.
nodes were free of metastatic disease. The complications following bladder instillation of BCG are Six months prior to admission to our institution, he devellargely confined to local tissues and most commonly consist oped right-hip pain, which was intermittently associated with of cystitis (90%), hematuria (30% -40%), and granulomatous rigors and sweats. He denied fevers, weight loss, weakness, prostatitis (1% -2%) [1] . Because of the low virulence of this anesthesias, and paresthesias. Radiography of the right hip reorganism, systemic complications occur in õ1% of the patients vealed both osteolytic and osteoblastic changes. An extensive, but include BCG sepsis, pneumonitis, hepatitis, and, rarely, inconclusive evaluation followed, which revealed that the com-BCG osteomyelitis. There are only five cases of the latter replete blood cell count and erythrocyte sedimentation rate were ported in the literature, all representing cases of vertebral osteonormal and that two bacterial cultures of joint aspirates were myelitis.
negative. A bone scan showed intense activity around the prosSimilarly, BCG infection involving an extravascular device thesis, needle and core biopsies showed lytic bone without is rare; only one case report of infection associated with an metastatic disease, and a second set of bacterial cultures was automated implantable cardiac defibrillator (AICD) has been negative. A technetium-labeled WBC scan showed no localizapublished [2] . We report herein a case of M. bovis osteomyelitis tion, and an MRI revealed no metastatic disease. involving a hip arthroplasty following intravesicular adminisIntraarticular administration of bupivacaine hydrochloride tration of BCG for superficial papillary transitional cell carciand oral analgesics failed to relieve the patient's pain, but a 2-noma of the bladder.
week course of ciprofloxacin, administered for possible cellulitis of the right thigh, brought significant relief. However, the Case Report pain recurred after completion of the antibiotic therapy. At our hospital, an arthrogram confirmed the loosening of the patient's In October 1995 a 66-year-old man with non-insulin-depenhip arthroplasty, and he underwent removal of the prosthesis dent diabetes presented with progressive right-buttock and along with extensive open bone biopsies. Histopathologic examination of the right femur revealed noncaseating granulomas. Cultures for bacteria and fungi were of his treatment with BCG. M. bovis is susceptible to ciintravesicular instillations of mitomycin and subsequently underwent a radical cystectomy, any of which may have caused profloxacin, which explained the patient's significant improvement during this therapy. disruption of the uroepithelium and thus a port of entry for persistent BCG. The patient's hip was stabilized with cement beads and a proximal tibial pin, and treatment with isoniazid and rifampin Given the paucity of data, it is premature to conclude whether or not patients with indwelling foreign devices (such as pacewas initiated. An open surgical biopsy of the right hip was again performed in September 1996 (3 months after completion makers and joint prostheses) who undergo intravesicular instillations of BCG require prophylaxis to prevent dissemination of 6 months of therapy), and AFB cultures were negative. However, histopathologic examination revealed granulomas of BCG to the device. However, even if prophylaxis were to be considered, it appears to be ineffective in preventing the containing fluorescence-positive bacilli.
The patient began receiving isoniazid and rifampin again dissemination of BCG. In a case reported by Fishman et al. [4] , BCG vertebral osteomyelitis resulted despite the adminisbut discontinued treatment shortly afterward when his spouse suddenly died. On 8 December 1997 small-cell carcinoma of tration of isoniazid (300 mg q.d.) throughout the duration of a 6-week course of intravesicular BCG. Thompson and Cumming the lung was diagnosed, of which he subsequently died on 16 March 1998.
[8] also have reported a case of granulomatous hepatitis that occurred despite prophylaxis with isoniazid (600 mg for 2 days) after each bladder instillation of BCG. Furthermore, there is Discussion the theoretical concern that prophylaxis will alter the antitumor activity of BCG; however, there are no data validating this This patient presented with BCG osteomyelitis, a rare comconcern. plication of bladder cancer treatment with intravesicular BCG.
What is clear is that even long after patients have completed Review of the English-language literature reveals only five intravesicular BCG therapy, the index of suspicion for BCG case reports of BCG osteomyelitis [2 -6] , and all are cases of infections at distant sites, including sites containing an indwellvertebral osteomyelitis presenting months to years following ing foreign device, must remain high. Successful treatment administration of intravesicular BCG. To our knowledge, this likely mandates removal of the infected device, in addition to represents the first reported case of M. bovis osteomyelitis administration of two to three antimycobacterial drugs. The involving a joint prosthesis, and although this raises concern appropriate duration of therapy is unclear and may require for the safety of patients with indwelling foreign devices who histopathologic and culture guidance. must undergo treatment with intravesicular BCG, the literature contains only one other case report of infection of an AICD
